Ontology highlight
ABSTRACT:
SUBMITTER: Han W
PROVIDER: S-EPMC3229606 | biostudies-other | 2011
REPOSITORIES: biostudies-other
Han Weidong W Sun Jie J Feng Lifeng L Wang KaiFeng K Li Da D Pan Qin Q Chen Yan Y Jin Wei W Wang Xian X Pan Hongming H Jin Hongchuan H
PloS one 20111202 12
Anthracycline daunorubicin (DNR) is one of the major antitumor agents widely used in the treatment of myeloid leukemia. Unfortunately, the clinical efficacy of DNR was limited because of its cytotoxity at high dosage. As a novel cytoprotective mechanism for tumor cell to survive under unfavorable conditions, autophagy has been proposed to play a role in drug resistance of tumor cells. Whether DNR can activate to impair the sensitivity of cancer cells remains unknown. Here, we first report that D ...[more]